Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Plc | 0.00% | 78.72 | 5.6% | $203.03m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 0.02% | 26.38 | 14.1% | $155.22m | |
| CTLT | Catalent, Inc. | 0.00% | 115.50 | 2.1% | $113.12m | |
| BHC | Bausch Health Cos., Inc. | 0.02% | 26.38 | 0.0% | $93.53m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.00% | 167.71 | 2.4% | $90.50m | |
| UTHR | United Therapeutics Corp. | 0.00% | 172.82 | 14.1% | $69.47m | |
| SAGE | SAGE Therapeutics, Inc. | 0.00% | 91.38 | 7.6% | $54.80m | |
| ACST | Acasti Pharma, Inc. | 0.00% | 0.60 | 0.2% | $50.70m | |
| PRGO | Perrigo Co. Plc | -0.05% | 43.69 | 6.8% | $50.20m | |
| GWPH | GW Pharmaceuticals Plc | 0.00% | 135.73 | 6.1% | $47.13m | |
| AMRN | Amarin Corp. Plc | 0.00% | 6.07 | 1.5% | $46.60m | |
| ISR | IsoRay, Inc. | -1.52% | 1.95 | 2.5% | $45.38m | |
| ICLR | ICON plc | 0.00% | 210.35 | 4.2% | $41.84m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 0.00% | 27.45 | 16.8% | $38.13m | |
| PCRX | Pacira Biosciences, Inc. | 0.00% | 73.68 | 10.0% | $37.63m |
Company Profile
Verona Pharma Plc operates as a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. Its lead product candidate, ensifentrine, has the potential to be the first therapy for the treatment of respiratory diseases that combines bronchodilator and anti-inflammatory activities in one compound. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.